Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan

J Epidemiol. 2023 Feb 5;33(2):110-111. doi: 10.2188/jea.JE20220265. Epub 2022 Nov 30.

Authors

Naomi Matsumoto¹, Junya Shimizu², Yuji Yokoyama³, Hirokazu Tsukahara⁴, Takashi Yorifuji¹

Affiliations

¹ Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
² Department of Pediatrics, National Hospital Organization, Okayama Medical Center.
³ Department of Pediatrics, Okayama Aiiku Clinic.
⁴ Department of Pediatrics, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Attitude
BNT162 Vaccine*
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Child
Humans
Japan / epidemiology

Substances

BNT162 Vaccine
COVID-19 Vaccines